Dexcel Pharma

About

Q&A

What is Dexcel Pharma's primary focus?

Dexcel Pharma specializes in the discovery, development, manufacture, and commercialization of innovative pharmaceutical products, particularly focusing on new formulations of known molecules and complex generic drugs using proprietary controlled-release technologies.

When was Dexcel Pharma founded?

Dexcel Pharma was founded in January 1965.

Where is Dexcel Pharma headquartered?

Dexcel Pharma is headquartered in Yokne'am Illit, Israel.

What is an example of a product developed by Dexcel Pharma?

An example is PerioChip, a product that offers a new approach to treating gum disease by using a small chip inserted under the gums.

How many employees does Dexcel Pharma have?

Dexcel Pharma has 500+ employees.

What markets does Dexcel Pharma target with its development pipeline?

Dexcel Pharma's development pipeline, which includes over 30 novel 505(b)2 formulations and complex generics, targets markets in the U.S. and the EU.

What is Dexcel Pharma's current stage according to startupim data?

According to startupim data, Dexcel Pharma is currently in the 'Mature' stage.

Does Dexcel Pharma have international offices?

Yes, Dexcel Pharma has offices in Germany, the United Kingdom, and Singapore, in addition to multiple locations in Israel.

Team · 1

Dan Oren

Founder · Founder

Sectors & technology

Tags